Diagnostic News and Research

RSS

Fibromyalgia diagnosis: an interview with Dr. Bruce Gillis, CEO of EpicGenetics

Presently, it is a diagnosis of exclusion. Patients end up spending, according to what’s been published in the medical literature, as many as 3 - 5 years going from doctor to doctor seeking a diagnosis because they tend to have nonspecific symptoms of a subjective nature.

23 Jul 2013

Study documents reversal of established medical practices in last decade

While there is an expectation that newer medical practices improve the standard of care, the history of medicine reveals many instances in which this has not been the case. Reversal of established medical practice occurs when new studies contradict current practice. Reporters may remember hormone replacement therapy as an example of medical reversal. A new analysis published in Mayo Clinic Proceedings documents 146 contemporary medical practices that have subsequently been reversed.

23 Jul 2013

Researchers receive grants from NASA to study muscle and bone loss during space travel

Dr. Miaozong Wu of the Center for Diagnostic Nanosystems at the Marshall University School of Pharmacy has been awarded a $750,000 grant from NASA to lead a team of researchers investigating the muscle and bone loss associated with space travel.

23 Jul 2013

Results of post-mortem brain tissue study using Navidea's NAV4694 imaging agent presented at AAIC 2013

Navidea Biopharmaceuticals, Inc., a biopharmaceutical company focused on precision diagnostic radiopharmaceuticals, today announced that researchers at McGill Center for Studies in Aging, Douglas Research Institute and Montreal Neurological Institute presented results of a post-mortem brain tissue study using Navidea's investigational Fluorine-18 labeled β-amyloid imaging agent, NAV4694, during the Alzheimer's Association International Conference in Boston, MA.

23 Jul 2013

New finding provides fresh hope for women with oestrogen receptor positive breast cancer

A new finding provides fresh hope for the millions of women worldwide with oestrogen receptor positive breast cancer. Australian scientists have shown that a specific change, which occurs when tumours become resistant to anti-oestrogen therapy, might make the cancers susceptible to treatment with chemotherapy drugs.

23 Jul 2013

Great Lakes NeuroTechnologies receives patent for Parkinson’s disease monitoring technology

Great Lakes NeuroTechnologies announced today they have received allowance of claims from the U.S. Patent Office for an application covering their system and method of stimulating the brain during sleep to treat movement disorder symptoms.

22 Jul 2013

Fujikura to exercise option to license Cellmid’s midkine diagnostic technology

Cellmid Limited has received confirmation that Fujikura Kasei Co Ltd (Fujikura) will exercise its Option to licence the midkine (MK) diagnostic technology by paying the requisite JPY40 million (AUD 440,000) Milestone Fee.

22 Jul 2013

Experts join together to form Rhode Island Consortium for Autism Research and Treatment

Dozens of autism experts across a variety of specialties have joined together to form the Rhode Island Consortium for Autism Research and Treatment. The consortium will bring together researchers, physicians, scientists, service providers, educators and parents to collaborate on a broad range of research, education and advocacy projects.

22 Jul 2013

IMS Health study assesses effectiveness of healthcare system in India

While progress has been made in India over the past decade from both public and private sector initiatives, significant challenges persist in providing quality healthcare on an equitable, accessible and affordable basis across all regions and communities, according to a new IMS Institute for Healthcare Informatics study.

20 Jul 2013

Mayo Clinic, Banner Health work together on diagnostic test to identify early Parkinson's disease

Researchers from Mayo Clinic Arizona and Banner Sun Health Research Institute are working together on a diagnostic test to identify early Parkinson's disease in patients thanks to a $152,486 grant from The Michael J. Fox Foundation for Parkinson's Research.

19 Jul 2013

Early diagnosis of AD may prevent psychological and behavioral symptoms

Persons with Alzheimer's disease are able to manage their everyday activities longer and they suffer from less psychological and behavioural symptoms if the diagnosis is made and treatment begun at a very early phase of the disease, indicates a recent study conducted at the University of Eastern Finland.

19 Jul 2013

Quest Diagnostics completes sale of ibrutinib commercialization rights to Royalty Pharma

Quest Diagnostics Incorporated, the world's leading provider of diagnostic information services, announced today that it has completed the sale of its rights to royalties from commercialization of the drug candidate ibrutinib to Royalty Pharma, the industry leader in acquiring royalty interests in marketed and late stage biopharmaceutical products, for $485 million in cash.

From Quest Diagnostics 18 Jul 2013

Cost of emergency room visits for severe dizziness projected to reach $4.4 billion by 2015

A new Johns Hopkins research report says emergency room visits for severe dizziness have grown exponentially in recent years, with costs topping $3.9 billion in 2011 and projected to reach $4.4 billion by 2015.

18 Jul 2013

Dementia rates falling among UK's elderly population: Study

The proportion of people with dementia in the UK has fallen, according to new estimates from the first ever study to show how dementia prevalence has changed in the UK population over time, published in The Lancet.

17 Jul 2013

Long-term cannabis use, dopamine and motivation: an interview with Dr Michael Bloomfield, Department of Medicine at Imperial

We classified ‘long-term’ cannabis use as being regular, at least weekly, cannabis use for over 12 months. This is the period of time that’s used in the DSM-IV psychiatric diagnostic manual to classify substance use disorders. In our study the average duration of at least weekly use was just over four and a half years.

17 Jul 2013

Study: STD clinics could be a great place to offer cervical cancer screening

A new study found that STD clinics could provide important access to cervical cancer screenings for women who traditionally have trouble receiving these screenings because of lack of insurance or other obstacles.

17 Jul 2013

Recent advances put melanoma at the forefront of cancer research

A decade ago there was little doctors could do to help a patient with advanced-stage melanoma. Now it seems each week yields important new discoveries about the deadly skin cancer.

17 Jul 2013

Magnets could be used for directing stem cells, may help treat heart and vascular diseases

Magnets could be a tool for directing stem cells' healing powers to treat conditions such as heart disease or vascular disease.

17 Jul 2013

Qualigen's FastPack Vitamin D Immunoassay receives FDA clearance

Qualigen, Inc., a privately owned company that provides rapid, easy to use, fully quantitative diagnostic testing solutions, announced today that it has received 510(k) clearance from the United States Food and Drug Administration for its FastPack Vitamin D Immunoassay for use on its proprietary FastPack System for the rapid determination of vitamin D status.

16 Jul 2013

FDA approves Gilotrif for patients with late stage non-small cell lung cancer

Companion test also approved to identify appropriate patients The U.S. Food and Drug Administration today approved Gilotrif (afatinib) for patients with late stage (metastatic) non-small cell lung cancer (NSCLC) whose tumors express specific types of epidermal growth factor receptor (EGFR) gene mutations, as detected by an FDA-approved test. Lung cancer is the leading cause of cancer-related death among men and women.

16 Jul 2013

Diagnostic News and Research

Fibromyalgia diagnosis: an interview with Dr. Bruce Gillis, CEO of EpicGenetics

Study documents reversal of established medical practices in last decade

Researchers receive grants from NASA to study muscle and bone loss during space travel

Results of post-mortem brain tissue study using Navidea's NAV4694 imaging agent presented at AAIC 2013

New finding provides fresh hope for women with oestrogen receptor positive breast cancer

Great Lakes NeuroTechnologies receives patent for Parkinson’s disease monitoring technology

Fujikura to exercise option to license Cellmid’s midkine diagnostic technology

Experts join together to form Rhode Island Consortium for Autism Research and Treatment

IMS Health study assesses effectiveness of healthcare system in India

Mayo Clinic, Banner Health work together on diagnostic test to identify early Parkinson's disease

Early diagnosis of AD may prevent psychological and behavioral symptoms

Quest Diagnostics completes sale of ibrutinib commercialization rights to Royalty Pharma

Cost of emergency room visits for severe dizziness projected to reach $4.4 billion by 2015

Dementia rates falling among UK's elderly population: Study

Long-term cannabis use, dopamine and motivation: an interview with Dr Michael Bloomfield, Department of Medicine at Imperial

Study: STD clinics could be a great place to offer cervical cancer screening

Recent advances put melanoma at the forefront of cancer research

Magnets could be used for directing stem cells, may help treat heart and vascular diseases

Qualigen's FastPack Vitamin D Immunoassay receives FDA clearance

FDA approves Gilotrif for patients with late stage non-small cell lung cancer

A New Approach to Preventing Bladder Cancer Recurrence

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Latest News